Details for New Drug Application (NDA): 020186

✉ Email this page to a colleague

NDA 020186 describes ZIAC, which is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. Additional details are available on the ZIAC profile page.

The generic ingredient in ZIAC is bisoprolol fumarate; hydrochlorothiazide. There are twelve drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the bisoprolol fumarate; hydrochlorothiazide profile page.

Summary for 020186

Tradename:	ZIAC
Applicant:	Teva Branded Pharm
Ingredient:	bisoprolol fumarate; hydrochlorothiazide
Patents:	0

Suppliers and Packaging for NDA: 020186

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
ZIAC	bisoprolol fumarate; hydrochlorothiazide	TABLET;ORAL	020186	NDA AUTHORIZED GENERIC	Teva Pharmaceuticals USA, Inc.	0093-3241	0093-3241-01	100 TABLET, FILM COATED in 1 BOTTLE (0093-3241-01)
ZIAC	bisoprolol fumarate; hydrochlorothiazide	TABLET;ORAL	020186	NDA AUTHORIZED GENERIC	Teva Pharmaceuticals USA, Inc.	0093-3242	0093-3242-01	100 TABLET, FILM COATED in 1 BOTTLE (0093-3242-01)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	5MG;6.25MG
Approval Date:	Mar 26, 1993	TE:	AB	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	10MG;6.25MG
Approval Date:	Mar 26, 1993	TE:	AB	RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	2.5MG;6.25MG
Approval Date:	Mar 26, 1993	TE:	AB	RLD:	Yes

Expired US Patents for NDA 020186

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Teva Branded Pharm	ZIAC	bisoprolol fumarate; hydrochlorothiazide	TABLET;ORAL	020186-003	Mar 26, 1993	4,258,062	⤷ Get Started Free
Teva Branded Pharm	ZIAC	bisoprolol fumarate; hydrochlorothiazide	TABLET;ORAL	020186-002	Mar 26, 1993	4,258,062*PED	⤷ Get Started Free
Teva Branded Pharm	ZIAC	bisoprolol fumarate; hydrochlorothiazide	TABLET;ORAL	020186-001	Mar 26, 1993	4,258,062*PED	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.